Impact Biomedical (IBO) Preferred Shares (2023 - 2025)
Impact Biomedical (IBO) posted Preferred Shares of $60000.0 for Q3 2025, little changed on a QoQ basis from $60000.0 in Q2 2025, and little changed year-over-year from $60000.0 in Q3 2024.
Impact Biomedical (IBO) Preferred Shares (2023 - 2025) Analysis & Trends
Impact Biomedical's Preferred Shares history runs 3 years deep, the most recent figure standing at $60000.0 for Q3 2025.
- Quarterly Preferred Shares changed 0.0% year-over-year to $60000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $60000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $60.5 billion, up 100826635.0% from the prior year.
- Preferred Shares was $60000.0 for Q3 2025 at Impact Biomedical, roughly flat from $60000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $60.5 billion in Q4 2024 and bottomed at $60000.0 in Q4 2023.
- A 3-year average of $7.6 billion and a median of $60000.0 in 2023 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2024 — Preferred Shares soared 100826635.0% — and 2025, when it changed 0.0%.
- Impact Biomedical's Preferred Shares stood at $60000.0 in 2023, then surged by 100826635.0% to $60.5 billion in 2024, then plunged by 100.0% to $60000.0 in 2025.
- Business Quant data shows IBO's Preferred Shares at $60000.0 in Q3 2025, $60000.0 in Q2 2025, and $60000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 60.50 Bn |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 60,000.00 |
| Dec 31, 2023 | 60,000.00 |